Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTECT Study: Preservation of Renal Function in Liver Transplant Recipients with Certican Therapy
2005-002920-32Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of everolimus in graft rejection (2 arms), sponsored by Novartis. Started Dec 2005; status: completed.
02
Drugs
everolimus
03
Conditions
graft rejection
Beyond the preview
Go deeper on 2005-002920-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002920-32.